𝔖 Bobbio Scriptorium

✦ LIBER ✦

Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)

✍ Scribed by Atif J. Khan; Par S. Mehta; Thomas W. Zusag; Philip D. Bonomi; L. Penfield Faber; Susan Shott; Ross A. Abrams

Book ID: 118496773
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 65 KB
Volume: 81
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2006.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aggressive therapy for patients with non

Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival

✍ Gray, Phillip J.; Mak, Raymond H.; Yeap, Beow Y.; Cryer, Sarah K.; Pinnell, Nanc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 347 KB

6570 POSTER Results for progression-free

6570 POSTER Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) are comparable when analysed by similar populations and methodology

✍ Sandler, A.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB